SE356520B - - Google Patents

Info

Publication number
SE356520B
SE356520B SE04843/68A SE484368A SE356520B SE 356520 B SE356520 B SE 356520B SE 04843/68 A SE04843/68 A SE 04843/68A SE 484368 A SE484368 A SE 484368A SE 356520 B SE356520 B SE 356520B
Authority
SE
Sweden
Application number
SE04843/68A
Inventor
E Jucker
A Ebnoether
E Rissi
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE356520B publication Critical patent/SE356520B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE04843/68A 1967-04-19 1968-04-10 SE356520B (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH558967A CH497458A (de) 1967-04-19 1967-04-19 Verfahren zur Herstellung neuer Phenothiazin-Derivate
CH1705667 1967-12-05

Publications (1)

Publication Number Publication Date
SE356520B true SE356520B (fr) 1973-05-28

Family

ID=25698043

Family Applications (2)

Application Number Title Priority Date Filing Date
SE04843/68A SE356520B (fr) 1967-04-19 1968-04-10
SE05102/71A SE361884B (fr) 1967-04-19 1968-04-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE05102/71A SE361884B (fr) 1967-04-19 1968-04-10

Country Status (17)

Country Link
US (1) US3531480A (fr)
AT (2) AT292726B (fr)
AU (2) AU5480273A (fr)
BE (1) BE713802A (fr)
BG (1) BG17326A3 (fr)
CH (1) CH497458A (fr)
DE (1) DE1770218A1 (fr)
ES (1) ES352822A1 (fr)
FR (1) FR1583822A (fr)
GB (2) GB1223315A (fr)
IE (2) IE32169B1 (fr)
IL (2) IL36239A (fr)
NL (1) NL6804983A (fr)
NO (1) NO124997B (fr)
OA (1) OA03386A (fr)
RO (1) RO54395A (fr)
SE (2) SE356520B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857943A (en) * 1969-03-27 1974-12-31 May & Baker Ltd New phenothiazine derivatives in the treatment of spasticity of muscles
CH511886A (de) * 1969-07-08 1971-08-31 Sandoz Ag Verfahren zur Herstellung neuer Furanonderivate
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
US6310059B1 (en) 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
WO2007133481A2 (fr) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Méthode d'augmentation de la biodisponibilité de composés contenant de la benzhydrylpipérazine
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
JP2014507424A (ja) 2011-03-08 2014-03-27 ザリカス ファーマスーティカルズ リミテッド 固体分散物製剤およびその使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212031A (fr) * 1957-10-21 1960-03-21 Rhone Poulenc Sa Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation

Also Published As

Publication number Publication date
US3531480A (en) 1970-09-29
FR1583822A (fr) 1969-12-05
GB1223314A (en) 1971-02-24
IE32170L (en) 1968-10-19
IE32169B1 (en) 1973-05-02
GB1223315A (en) 1971-02-24
DE1770218A1 (de) 1971-10-14
RO54395A (fr) 1973-02-17
AU5480173A (en) 1973-07-12
IL29842A0 (en) 1968-06-20
BG17326A3 (fr) 1973-07-25
IE32170B1 (en) 1973-05-02
AU5480273A (en) 1973-07-12
AT292726B (de) 1971-09-10
IE32169L (en) 1968-10-19
IL29842A (en) 1971-05-26
AT293372B (de) 1971-10-11
CH497458A (de) 1970-10-15
NL6804983A (fr) 1968-10-21
OA03386A (fr) 1970-12-15
NO124997B (fr) 1972-07-03
ES352822A1 (es) 1969-11-16
SE361884B (fr) 1973-11-19
IL36239A (en) 1971-06-23
BE713802A (fr) 1968-10-17

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AT298283B (fr)
FR1583822A (fr)
AU416737B2 (fr)
AU2277767A (fr)
AU342066A (fr)
FR7671M (fr)
AU2256867A (fr)
AU3151267A (fr)
AU2116667A (fr)
AU2454867A (fr)
AU610966A (fr)
AU2528767A (fr)
AU1273466A (fr)
AU2977667A (fr)
AU3189468A (fr)
AU2406369A (fr)
AU25066A (fr)
AU34866A (fr)
AU408412B2 (fr)
BE509738A (fr)
AU23366A (fr)
AU1868267A (fr)
AU459699A (fr)
AU1763766A (fr)